<DOC>
	<DOCNO>NCT01675258</DOCNO>
	<brief_summary>Colorectal cancer account 783,000 new case cause 437,000 death per year across world . Diagnosis early stage improve survival rate . Up , cancer mostly diagnose later stage disease 's course histoimmune stain molecular biology process tissue biopsied gastrointestinal system invasive diagnostic procedure colonoscopy . Oral fluid present large protein complexity recently use diagnostic biofluid oral , well systematic disease . Using oral fluid bio-marker colorectal cancer advantageous contain gastrointestinal fluid , addition bacteria bacteria lysate , also serve bio-markers ' source colorectal cancer . Proteomic technology provide tool need discover identify disease-associated biomarkers . The aim present study identify salivary bio-markers patient suffer colorectal cancer .</brief_summary>
	<brief_title>Identifying Saliva Markers Patients With Stomach , Colorectal ( Including Pre-cancer Polyp ) Pancreatic Cancers</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Polyps</mesh_term>
	<criteria>Has yet start treatment identify cancer medically compromise patient congenital syndromes treated radiotherapy chemotherapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>